Revolo Biotherapeutics Enters Manufacturing Agreement with CordenPharma to Scale Up and Manufacture ‘1104 for the Treatment of Eosinophilic Esophagitis and Allergic Disease

Matt Turner
Patient Affordability

Daniel Sontupe
Market Access

Pat Purcell
Meeting Engagement

Frank Burrell
Scientific Storytelling

Bud Bilanich
Success Coach

Matthew Durham
Omnidynamic Marketing

Amy Giles
Increasing Engagement

David Linetsky
Point-of-Care Marketing

Suma Ramadas, PhD
Medical Affairs

Stacey Gandler
Brand Nourishment

Brenda Snow
Authentic Patient Voice

Liz Kane
Impactful Strategy

Paul Theisen
Patient Acquisition

Joey Cohen
Medication Adherence